All PHCs in Tiruchy to start COPD screening from June 4
TIRUCHY: From June 4, all 84 primary health centres (PHCs) in the district, including those under the corporation, will launch structured screening for Chronic Obstructive Pulmonary Disease (COPD), a progressive lung condition often under-diagnosed in its early stages.
The initiative, which is part of the COPD control programme announced recently in the state Assembly by Health Minister Ma Subramanian, aims to enable early identification of cases and ensure timely referral to specialists.
It is also part of efforts, to maintain through the PHCs, a digital registry integrated with the Makkalai Thedi Maruthuvam (MTM) portal, supporting both long-term treatment and preparedness during respiratory outbreaks.
Under the new programme, adults above 35 years presenting with symptoms such as chronic cough (lasting more than eight weeks), sputum production and breathlessness, and particularly with a history of smoking, indoor biomass fuel use and dust-heavy occupations, will be screened for COPD at PHCs. If needed, they will be referred to the Mahatma Gandhi Memorial Government Hospital (MGMGH).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
a day ago
- The Hindu
Karnataka's Health Department extends Gruha Arogya scheme across State
For early detection and management of non-communicable diseases (NCD) among people in rural areas, Karnataka's Health Department has now extended the Gruha Arogya (doorstep healthcare) scheme across the State. The scheme that was formally launched by Chief Minister Siddaramaiah on October 24 last year was initially piloted in Kolar district, where dedicated health teams conducted door-to-door screening for major NCDs. Following its success, the initiative is now being scaled up to all districts, announced Health Minister Dinesh Gundu Rao on Monday. Major NCDs During the pilot project, screening was conducted for major NCDs, including Diabetes, Hypertension, three common cancers - Oral, Breast and Cervical cancer (the latter two for females) in individuals aged 30 years and above. Now, ASHA workers will conduct door-to-door visits to raise awareness about NCDs and facilitate health check-ups for individuals above 30 at Ayushman Health and Wellness Centres. Community Health Officers (CHOs) will conduct screenings for 14 NCDs, including hypertension, diabetes, and cancer, and record the data on the NCD portal. Free medication and regular follow-up care will be provided at the nearest Ayushman Health and Wellness centres to those diagnosed, the Minister said. Apart from Diabetes, Hypertension, Oral Cancer, Breast Cancer, Cervical Cancer, the other NCDs to be covered under the scheme include Diabetic Foot, Mental Health Disorders, Neurological Disorders, Obstructive Sleep Apnea, Diabetic Retinopathy, Chronic Kidney Disease (CKD), Chronic Obstructive Pulmonary Disease (COPD), Non-Alcoholic Fatty Liver Disease (NAFLD) and Anemia (19-29 yrs). Five houses a day Srinivas G., State Deputy Director (Non-Communicable Diseases) said ASHA workers will visit the households under their jurisdiction on all working days of the week (excluding State-declared holidays), covering approximately four to five houses per day. During these visits, they will register all members of the household in the ASHA application on the NCD portal. The CHOs, who will provide screening, diagnosis, management, and treatment of all NCDs for individuals aged 30 years and above, will refer the suspected cases and patients with diabetes for confirmation through tele-consultation. 'CHOs will conduct screening, management and treatment services for walk-in patients at Ayushman Health Centres every Monday, Tuesday, Thursday and Saturday. On Wednesdays and Fridays, CHOs will conduct outreach activities and organise NCD screening camps in coordination with ASHA workers,' he said. 'Patients under treatment will receive regular follow-up, including re-examinations and necessary support for a period of up to two months,' he added.
The Hindu
a day ago
- The Hindu
COPD, hypertension and diabetes detection drive planned in Tiruchi district
Health authorities will be organising awareness programmes and early screening for Chronic Obstructive Pulmonary Diseases (COPD) as well launching a service to detect hypertension and diabetes among workers in small commercial establishments in Tiruchi district this week as part of a Statewide initiative to integrate them under the Makkalai Thedi Maruthuvam (MTM) scheme. According to an official press release, the COPD programmes will be launched on June 4 under the supervision of the State Nnon-communicable Diseases (NCD) Section with the support of National Health Mission-Tamil Nadu. COPD is a long-term lung disease causing persistent cough and breathlessness, especially common in people exposed to smoke and dust. Symptoms include chronic cough for over eight weeks, breathlessness during daily activity, wheezing or chest tightness and sputum production. Smokers, users of biomass fuels, and people working in dusty environments are at high risk of COPD. The programme will involve the participation of all the 84 Primary Health Centres, including those under Tiruchi Corporation, that have been mapped to their nearest tertiary care centre and functional spirometry facility (Mahatma Gandhi Memorial Government Hospital), said the release. Spirometry tests will be available free of cost at designated centres. Monthly results of the screening would be reported to the State NCD Section. On June 5, a programme to screen 25,571 workers in nearly 878 factories and small commercial establishments for hypertension and diabetes will be launched in Tiruchi district, covering the blocks of Lalgudi, Manapparai, Manachallur, Marungapuri, Musiri, Thiruverumbur, Thuraiyur, Thottiyam, and Tiruchi Corporation. The firms with less than 1,000 employees were identified through the Directorate of Industrial Safety and Health (DISH) for the programme. The initiative will be implemented through the existing Mobile Medical Units (MMUs) – both Regular and Tribal – without deviation from the fixed tour programme by integrating workplace screening with routine outreach activities at the block level. The programme aim at promoting early detection of hypertension and diabetes among labourers, and ensure timely referral of suspected/confirmed NCD cases to the nearest government health facility for further management. Over 5 lakh workers had been identified for the programme throughout the State, said the release.
New Indian Express
2 days ago
- New Indian Express
FDA approves Moderna's next-generation COVID-19 vaccine: Here's what makes it different
CHENNAI: The US Food and Drug Administration (FDA) on Saturday officially approved Moderna's next-generation COVID-19 vaccine for use in key high-risk populations. This marks the first FDA endorsement of a COVID-19 vaccine since the agency revised its regulatory guidelines to tighten standards for safety and efficacy reviews. The US drug regulator had recently announced that it will limit the use of the COVID-19 vaccine to certain groups. This follows updated guidance from the Centers for Disease Control and Prevention (CDC)—the agency responsible for monitoring disease trends and vaccine safety—which no longer recommends the vaccine for several categories of individuals, including pregnant people and healthy children. According to an FDA note reviewed by The New Indian Express, the vaccine is approved for Adults aged 65 and older — blanket approval for all individuals in this age group, Individuals aged 12 to 64 with underlying risk factors — approval applies to those who have at least one or more underlying health conditions, including chronic respiratory conditions such as asthma, COPD, cardiovascular disease, diabetes and obesity. The vaccine is also approved for use in individuals below 65 years old if they are in immunocompromised states like cancer and undergoing cancer treatment.
